vitamin-k-1 and Metabolic-Syndrome

vitamin-k-1 has been researched along with Metabolic-Syndrome* in 4 studies

Trials

2 trial(s) available for vitamin-k-1 and Metabolic-Syndrome

ArticleYear
Association between Circulating Osteocalcin and Cardiometabolic Risk Factors following a 4-Week Leafy Green Vitamin K-Rich Diet.
    Annals of nutrition & metabolism, 2020, Volume: 76, Issue:5

    Evidence suggests that lower serum undercarboxylated osteocalcin (ucOC) may be negatively associated with cardiometabolic health. We investigated whether individuals with a suppression of ucOC following an increase in dietary vitamin K1 exhibit a relative worsening of cardiometabolic risk factors.. Men (n = 20) and women (n = 10) aged 62 ± 10 years participated in a randomized, controlled, crossover study. The primary analysis involved using data obtained from participants following a high vitamin K1 diet (HK; 4-week intervention of increased leafy green vegetable intake). High and low responders were defined based on the median percent reduction (30%) in ucOC following the HK diet. Blood pressure (resting and 24 h), arterial stiffness, plasma glucose, lipid concentrations, and serum OC forms were assessed.. Following the HK diet, ucOC and ucOC/tOC were suppressed more (p < 0.01) in high responders (41 and 29%) versus low responders (12 and 10%). The reduction in ucOC and ucOC/tOC was not associated with changes in blood pressure, arterial stiffness, plasma glucose, or lipid concentrations in the high responders (p > 0.05).. Suppression of ucOC via consumption of leafy green vegetables has no negative effects on cardiometabolic health, perhaps, in part, because of cross-talk mechanisms.

    Topics: Aged; Blood Glucose; Blood Pressure; Cardiometabolic Risk Factors; Cross-Over Studies; Diet; Eating; Female; Humans; Lipids; Male; Metabolic Syndrome; Middle Aged; Osteocalcin; Plant Leaves; Vascular Stiffness; Vegetables; Vitamin K 1

2020
Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome.
    Nutrition research (New York, N.Y.), 2011, Volume: 31, Issue:5

    Metabolic syndrome poses additional risk for postmenopausal women who are already at risk for osteoporosis. We hypothesized that a nutritional supplement containing anti-inflammatory phytochemicals and essential bone nutrients would produce a favorable bone biomarker profile in postmenopausal women with metabolic syndrome. In this 14-week, randomized trial, 51 women were instructed to consume a modified Mediterranean-style, low-glycemic-load diet and to engage in aerobic exercise. Those in the intervention arm (n = 25) additionally received 200 mg hop rho iso-alpha acids, 100 mg berberine sulfate trihydrate, 500 IU vitamin D₃, and 500 μg vitamin K₁ twice daily. Forty-five women completed the study. Baseline nutrient intake did not differ between arms. Compared with baseline, the intervention arm exhibited an approximate 25% mean decrease (P < .001) in serum osteocalcin (indicative of bone turnover), whereas the placebo arm exhibited a 21% increase (P = .003). Serum 25-hydroxyvitamin D increased 23% (P = .001) in the intervention arm and decreased 12% (P = .03) in the placebo arm. The between-arm differences for osteocalcin and 25-hydroxyvitamin D were statistically significant. Serum insulin-like growth factor I was statistically increased in both arms, but the between-arm differences were not statistically significant. Subanalysis showed that among those in the highest tertile of baseline insulin-like growth factor I, the intervention arm exhibited a significant increase in amino-terminal propeptide of type I collagen, whereas the placebo arm showed a significant decrease at 14 weeks. Treatment with rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produced a more favorable bone biomarker profile indicative of healthy bone metabolism in postmenopausal women with metabolic syndrome.

    Topics: Anti-Inflammatory Agents; Berberine; Biomarkers; Bone and Bones; Cholecalciferol; Collagen Type I; Dietary Supplements; Female; Humans; Humulus; Insulin-Like Growth Factor I; Metabolic Syndrome; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Phytotherapy; Plant Extracts; Single-Blind Method; Vitamin D; Vitamin K 1; Vitamins

2011

Other Studies

2 other study(ies) available for vitamin-k-1 and Metabolic-Syndrome

ArticleYear
Association Between Vitamin K and the Metabolic Syndrome: A 10-Year Follow-Up Study in Adults.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6

    The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities and is associated with increased risk of diabetes and cardiovascular diseases. Phylloquinone, menaquinones, and vitamin K status are associated with several components of MetS, but the association with MetS has hardly been studied to date.. This study aimed to examine whether the intake and/or status of vitamin K is associated with MetS and its components.. This study comprised two cohorts, one of 402 women and one of 400 men (age 40-80 y). At followup 625 participants were still alive and willing to participate. Data were analyzed both cross sectionally and longitudinally with Poisson and linear regression adjusted for multiple confounders. Baseline phylloquinone/menaquinone intakes were measured with a validated food frequency questionnaire and vitamin K status with serum desphospho-uncarborxylated matrix-Gla protein level.. At baseline 270 (34.5%) participants had MetS and 171 (35.7%) at followup. Cross sectionally, high menaquinones intakes were associated (P(trend) = .08) with a lower prevalence of MetS with a prevalence ratio (PR) of 0.74 (95% confidence interval [CI], 0.54-1.03) for the highest vs the lowest tertile. At followup, the highest tertiles of menaquinones intake (PR = 0.62; 95% CI, 0.40-0.95) and vitamin K status (PR = 0.57; 95% CI, 0.38-0.87) were associated (P(trend) = .01) with a lower occurrence of MetS. These associations were mainly driven by relations with lower triacylglycerol concentrations for menaquinones and lower waist circumference for vitamin K status. Phylloquinone intake was not associated with MetS prevalence.. This study shows that a high intake of menaquinones and high vitamin K status are associated with a lower occurrence of MetS.

    Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diet Surveys; Eating; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Vitamin K; Vitamin K 1; Vitamin K 2

2015
Dietary phylloquinone intakes and metabolic syndrome in US young adults.
    Journal of the American College of Nutrition, 2009, Volume: 28, Issue:4

    The relationship between dietary intake of vitamin K and metabolic syndrome (MetS) has not been investigated previously. The aim of this study was to examine whether and to what extent vitamin K intake measured as phylloquinone is related to MetS.. We performed a cross-sectional analysis on data from 5800 adults aged 20 to 45 years who participated in the National Health and Nutrition Examination Survey (NHANES) 1999-2004. MetS was defined according to Adult Treatment Panel III criteria. Dietary phylloquinone intakes were obtained from 24-hour dietary recall. Prevalence and odds ratios (OR) of MetS and its components were assessed by quartiles of dietary phylloquinone intake.. The lowest prevalence of MetS and its 5 components was observed in individuals with the highest phylloquinone intake. The prevalence of low high-density lipoprotein cholesterol (HDL) and elevated blood pressure progressively decreased with increasing phylloquinone intake (p < 0.05 for trend). HDL and C-reactive protein (CRP) levels improved gradually with increasing dietary phylloquinone intake (p < 0.05 for trend). In general, participants who had MetS or its element consumed less phylloquinone from diet compared those who did not. In comparison with the lowest phylloquinone intake quartile, the highest quartile of intake was associated with significantly reduced risks of low HDL level, hypertriglyceridemia, and hyperglycemia after adjustment was made for various nondietary confounding factors (OR, 0.73, 95% confidence interval [CI], 0.45-0.98; OR, 0.51, 95% CI, 0.25-0.97; and OR, 0.18, 95% CI, 0.05-0.73, respectively). Only the association between hyperglycemia and phylloquinone intake remained significant after further adjustment for dietary confounders (OR, 0.18, 95% CI, 0.05-0.73).. Mean reported dietary phylloquinone intakes suggested that most US young adults consume an insufficient amount of vitamin K from their diet. A high intake of phylloquinone may favorably affect MetS or its components, probably through an overall more heart-healthy dietary pattern. The pathogenesis of MetS is profoundly complex and may involve other factors and/or mechanisms, in addition to vitamin K nutriture. Although our data suggest a potential role of vitamin K in MetS, the biological mechanisms underlying the observed associations must be elucidated.

    Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cross-Sectional Studies; Diet Surveys; Female; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Nutrition Surveys; Triglycerides; United States; Vitamin K 1; Vitamins; Waist Circumference; Young Adult

2009